NSC |
Compound |
Enrichment |
Correlation |
NSC 724631 |
4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.0112425217758228 |
0.23704883 |
NSC 733906 |
Null |
0.0112425217758228 |
-0.22550741 |
NSC 736164 |
pyrazoline derivative |
0.0112425217758228 |
0.42100524 |
NSC 737613 |
Null |
0.0112425217758228 |
0.35724385 |
NSC 756304 |
GW678313X |
0.0112425217758228 |
-0.36867056 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0112425217758228 |
0.36152011 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0112425217758229 |
0.60414244 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0112425217758229 |
0.28306826 |
NSC 637921 |
1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- |
0.0114553853234974 |
-0.36977083 |
NSC 638241 |
Null |
0.0114553853234974 |
0.43904263 |